{
  "text": "Reversible myopathy due to labetalol.\n A severe, generalized myopathy developed in 2 children treated with labetalol.\n An 11-year-old girl and a 14-year-old boy demonstrated proximal weakness and markedly elevated creatine kinase levels during labetalol therapy.\n Clinical improvement began immediately when labetalol administration was halted; muscle strength was normal within 2 months.\n Muscle biopsies were consistent with rhabdomyolysis.",
  "category": "C23"
}